Loading clinical trials...
Loading clinical trials...
A Single-arm, Multicenter, Phase II Study to Evaluate Cadonilimab（AK104） Combined With Radiotherapy For The Treatment of Locally Advanced Cervical Cancer
Conditions
Interventions
Cadonilimab（AK104）
EBRT
+1 more
Locations
1
China
Chongqing university Cancer Hospital
Chongqing, CHN, China
Start Date
December 29, 2022
Primary Completion Date
December 30, 2024
Completion Date
December 1, 2026
Last Updated
September 19, 2024
NCT05975593
NCT07104149
NCT06288373
NCT05378087
NCT05950087
NCT05311566
Lead Sponsor
Chongqing University Cancer Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions